{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:02:29Z","timestamp":1789534949067,"version":"build-2803163510"},"reference-count":37,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:00:00Z","timestamp":1789257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Implantable cardioverter-defibrillators (ICDs) were historically viewed as a barrier to vigorous or competitive sport participation, based on theoretical concerns about arrhythmia induction, inappropriate shocks, device damage, and shock-related injury during activity. Contemporary registry data have reframed this paradigm, demonstrating that selected athletes with ICDs can participate in organized sport without the catastrophic outcomes once feared, although these data remain reassuring rather than definitive given selection bias and underrepresentation of high-consequence sports. This review synthesizes contemporary athlete-specific registry data and broader randomized device and programming evidence, alongside current guideline recommendations, to provide a practical framework for the care of athletes with ICDs, addressing indications, which should remain diagnosis-driven rather than sport-driven; device selection, weighing transvenous, subcutaneous, and extravascular platforms against an athlete\u2019s pacing needs, anatomy, and sport-specific trauma risk; and exercise-informed device programming. We then present a longitudinal framework integrating clinical readiness, device readiness, sport-specific risk, emergency preparedness, shared decision-making, and reassessment after clinical or sporting changes. Special populations and priorities for future research are also discussed. Rather than a binary clearance decision, modern management of athletes with ICDs requires an individualized, longitudinally reassessed approach to risk.<\/jats:p>","DOI":"10.3390\/jcm15187103","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:09:51Z","timestamp":1789387791000},"page":"7103","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Athletes with Implantable Cardioverter-Defibrillators: A Practical Framework for Device Selection, Programming, and Return-to-Sport Risk Mitigation"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-6580","authenticated-orcid":false,"given":"Demetrio","family":"Sharp Dimitri","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5333-1984","authenticated-orcid":false,"given":"Jordan M.","family":"Prutkin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2005.02.006","article-title":"Introduction: Eligibility recommendations for competitive athletes with cardiovascular abnormalities\u2014General considerations","volume":"45","author":"Maron","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jacc.2015.09.032","article-title":"Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Preamble, principles, and general considerations: A scientific statement from the American Heart Association and American College of Cardiology","volume":"66","author":"Maron","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.jacc.2015.09.041","article-title":"Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 9: Arrhythmias and conduction defects: A scientific statement from the American Heart Association and American College of Cardiology","volume":"66","author":"Zipes","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurheartj\/ehaa605","article-title":"2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease","volume":"42","author":"Pelliccia","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.112.000447","article-title":"Safety of sports for athletes with implantable cardioverter-defibrillators: Results of a prospective, multinational registry","volume":"127","author":"Lampert","year":"2013","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1161\/CIRCULATIONAHA.117.027828","article-title":"Safety of sports for athletes with implantable cardioverter-defibrillators: Long-term results of a prospective multinational registry","volume":"135","author":"Lampert","year":"2017","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e006305","DOI":"10.1161\/CIRCEP.118.006305","article-title":"Safety of sports for young patients with implantable cardioverter-defibrillators: Long-term results of the multinational ICD Sports Registry","volume":"11","author":"Saarel","year":"2018","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/2047487319834852","article-title":"Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort","volume":"26","author":"Heidbuchel","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.hrthm.2024.05.018","article-title":"2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to play","volume":"21","author":"Lampert","year":"2024","journal-title":"Heart Rhythm"},{"key":"ref_10","first-page":"e716","article-title":"Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology","volume":"151","author":"Kim","year":"2025","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e70131","DOI":"10.1002\/joa3.70131","article-title":"Return-to-play in athletes with transvenous and subcutaneous implantable cardiac defibrillator: A meta-analysis","volume":"41","author":"Eri","year":"2025","journal-title":"J. Arrhythmia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.hrthm.2024.09.039","article-title":"Long-term performance of subcutaneous implantable defibrillators in athletes: A multicenter, real-world analysis of sport activities from the iSUSI registry","volume":"22","author":"Gasperetti","year":"2025","journal-title":"Heart Rhythm"},{"key":"ref_13","first-page":"1257","article-title":"Exercise-guided programming of a subcutaneous implantable cardioverter-defibrillator in an athlete","volume":"11","author":"Hsieh","year":"2025","journal-title":"Hear. Case Rep."},{"key":"ref_14","first-page":"1267","article-title":"Hitting a new PR: Extravascular ICD implant in a professional powerlifter","volume":"11","author":"Earle","year":"2025","journal-title":"Hear. Case Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e009344","DOI":"10.1161\/CIRCEP.120.009344","article-title":"Implantable cardioverter defibrillator lead survival in athletic patients","volume":"14","author":"Link","year":"2021","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e013365","DOI":"10.1161\/CIRCEP.124.013365","article-title":"Subcutaneous Implantable Defibrillators in Young Patients: Arrhythmias, Complications, and Physical Activity","volume":"18","author":"Francia","year":"2025","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.hroo.2024.01.007","article-title":"Safety of Sports for Patients with Subcutaneous Implantable Cardioverter Defibrillator (SPORT S-ICD): Study rationale and protocol","volume":"5","author":"Chorin","year":"2024","journal-title":"Heart Rhythm O2"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJMoa2206485","article-title":"Efficacy and safety of an extravascular implantable cardioverter-defibrillator","volume":"387","author":"Friedman","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: A report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.048728","article-title":"Primary results from the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) trial","volume":"143","author":"Gold","year":"2021","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.7326\/M22-1566","article-title":"Perioperative safety and early patient and device outcomes among subcutaneous versus transvenous implantable cardioverter defibrillator implantations: A randomized, multicenter trial","volume":"175","author":"Healey","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.124.071795","article-title":"Performance and safety of the extravascular implantable cardioverter-defibrillator through long-term follow-up: Final results from the pivotal study","volume":"151","author":"Friedman","year":"2025","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2013.4598","article-title":"Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: The ADVANCE III randomized clinical trial","volume":"309","author":"Gasparini","year":"2013","journal-title":"JAMA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.hrthm.2015.01.017","article-title":"Low inappropriate shock rates in patients with single- and dual\/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results","volume":"12","author":"Auricchio","year":"2015","journal-title":"Heart Rhythm"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.hrthm.2015.11.018","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"13","author":"Wilkoff","year":"2016","journal-title":"Heart Rhythm"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.hrthm.2018.10.032","article-title":"Competitive athletes with implantable cardioverter-defibrillators\u2014How to program? Data from the Implantable Cardioverter-Defibrillator Sports Registry","volume":"16","author":"Olshansky","year":"2019","journal-title":"Heart Rhythm"},{"key":"ref_30","first-page":"143","article-title":"Inter-Association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: A consensus statement","volume":"42","author":"Drezner","year":"2007","journal-title":"J. Athl. Train."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12265-020-09988-1","article-title":"Design and implementation of an emergency action plan for sudden cardiac arrest in sport","volume":"13","author":"Pelto","year":"2020","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Tetaj, N., Segreti, A., Ferro, A., Ligorio, V., Spagnolo, A., and Grigioni, F. (2026). High-Risk Cardiomyopathy Genotypes and Arrhythmic Risk: LMNA, FLNC, RBM20, PLN and Desmosomal Genes in the ESC 2023 Era. Genes, 17.","DOI":"10.3390\/genes17040370"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Vecchiato, M., Egger, F., and Palermi, S. (2026). Sporting Careers After ICD Implantation in Elite Athletes. J. Cardiovasc. Dev. Dis., 13.","DOI":"10.3390\/jcdd13020097"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e029052","DOI":"10.1161\/JAHA.122.029052","article-title":"Rationale and Design of the ORCCA (Outcomes Registry for Cardiac Conditions in Athletes) Study","volume":"12","author":"Moulson","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jacc.2025.09.006","article-title":"2025 ACC\/AHA\/HRS\/ISACHD\/SCAI Guideline for the Management of Adults with Congenital Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"87","author":"Gurvitz","year":"2026","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7103\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:10:47Z","timestamp":1789531847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,13]]},"references-count":37,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15187103"],"URL":"https:\/\/doi.org\/10.3390\/jcm15187103","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,13]]}}}